These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Comparison of T24H-his, GST-T24H and GST-Ts8B2 recombinant antigens in western blot, ELISA and multiplex bead-based assay for diagnosis of neurocysticercosis. Hernández-González A; Noh J; Perteguer MJ; Gárate T; Handali S Parasit Vectors; 2017 May; 10(1):237. PubMed ID: 28506245 [TBL] [Abstract][Full Text] [Related]
25. The role of p130Cas/BCAR1 adaptor protein in the pathogenesis of cardiovascular diseases: A literature review. Ghasempour Dabaghi G; Rabiee Rad M; Amani-Beni R; Darouei B Am Heart J Plus; 2024 Aug; 44():100416. PubMed ID: 39036012 [TBL] [Abstract][Full Text] [Related]
26. Cas proteins: dodgy scaffolding in breast cancer. Tornillo G; Defilippi P; Cabodi S Breast Cancer Res; 2014; 16(5):443. PubMed ID: 25606587 [TBL] [Abstract][Full Text] [Related]
27. External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extracts. Sweep CG; Geurts-Moespot J; Grebenschikov N; de Witte JH; Heuvel JJ; Schmitt M; Duffy MJ; Jänicke F; Kramer MD; Foekens JA; Brünner N; Brugal G; Pedersen AN; Benraad TJ Br J Cancer; 1998 Dec; 78(11):1434-41. PubMed ID: 9836475 [TBL] [Abstract][Full Text] [Related]
28. BCAR1 expression in prostate cancer: association with 16q23 LOH status, tumor progression and EGFR/KAI1 staining. Fromont G; Vallancien G; Validire P; Levillain P; Cussenot O Prostate; 2007 Feb; 67(3):268-73. PubMed ID: 17192874 [TBL] [Abstract][Full Text] [Related]
29. Human kallikrein 10 ELISA development and validation in breast cancer sera. Ewan King L; Li X; Cheikh Saad Bouh K; Pedneault M; Chu CW Clin Biochem; 2007 Sep; 40(13-14):1057-62. PubMed ID: 17585892 [TBL] [Abstract][Full Text] [Related]
30. Tenascin-W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients. Degen M; Brellier F; Schenk S; Driscoll R; Zaman K; Stupp R; Tornillo L; Terracciano L; Chiquet-Ehrismann R; Rüegg C; Seelentag W Int J Cancer; 2008 Jun; 122(11):2454-61. PubMed ID: 18306355 [TBL] [Abstract][Full Text] [Related]
31. Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay. Mankaï A; Sakly W; Landolsi H; Gueddah L; Sriha B; Ayadi A; Sfar MT; Skandrani K; Harbi A; Essoussi AS; Korbi S; Fabien N; Jeddi M; Ghedira I Pathol Biol (Paris); 2005 May; 53(4):204-9. PubMed ID: 15850953 [TBL] [Abstract][Full Text] [Related]
32. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer. Allard WJ; Neaman IE; Elting JJ; Barnett TR; Yoshimura H; Fritsche HA; Yeung KK Cancer Res; 1994 Mar; 54(5):1227-34. PubMed ID: 8118811 [TBL] [Abstract][Full Text] [Related]
33. RP215 single chain fragment variable and single domain recombinant antibodies induce cell cycle arrest at G0/G1 phase in breast cancer. Yu F; Wang Y; Xiao Y; He Y; Luo C; Duan D; Li C; Xu S; Xiang T Mol Immunol; 2014 May; 59(1):100-9. PubMed ID: 24534066 [TBL] [Abstract][Full Text] [Related]
34. His-tag ELISA for the detection of humoral tumor-specific immunity. Goodell V; McNeel D; Disis ML BMC Immunol; 2008 May; 9():23. PubMed ID: 18510754 [TBL] [Abstract][Full Text] [Related]
35. Development of an enzyme-linked immunosorbent assay (ELISA) for quantification of skeletal muscle calpastatin. Doumit ME; Lonergan SM; Arbona JR; Killefer J; Koohmaraie M J Anim Sci; 1996 Nov; 74(11):2679-86. PubMed ID: 8923182 [TBL] [Abstract][Full Text] [Related]
36. Comparison of M22-based ELISA and human-TSH-receptor-based luminescence assay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases. Liu C; Hermsen D; Domberg J; Graeber C; Hautzel H; Duan Y; Xu KF; Liu CP; Mao XD; Cupisti K; Scherbaum WA; Schott M Horm Metab Res; 2008 Jul; 40(7):479-83. PubMed ID: 18504673 [TBL] [Abstract][Full Text] [Related]
37. Generation of monoclonal antibodies against peptidylarginine deiminase 2 (PAD2) and development of a PAD2-specific enzyme-linked immunosorbent assay. Damgaard D; Palarasah Y; Skjødt K; Catrina AI; Hensen SM; Pruijn GJ; Nielsen CH J Immunol Methods; 2014 Mar; 405():15-22. PubMed ID: 24384061 [TBL] [Abstract][Full Text] [Related]
38. Exploiting the avian immunoglobulin system to simplify the generation of recombinant antibodies to allergenic proteins. Finlay WJ; deVore NC; Dobrovolskaia EN; Gam A; Goodyear CS; Slater JE Clin Exp Allergy; 2005 Aug; 35(8):1040-8. PubMed ID: 16120086 [TBL] [Abstract][Full Text] [Related]
39. Development of polyclonal antibody-based indirect enzyme-linked immunosorbent assay for the detection of Alicyclobacillus strains in apple juice. Wang Z; Yue T; Yuan Y; Cai R; Guo C; Wang X; Niu C J Food Sci; 2012 Nov; 77(11):M643-9. PubMed ID: 23106215 [TBL] [Abstract][Full Text] [Related]